Welcome to Dermbits! Watch short videos of KOLs answering your questions

thumbnail_dermbits-colorful.png

dermbits-colorful.png

Dermbits

Who is eligible for treatment with bimekizumab? Are there any notable exclusion criteria?

Psoriasis

So as almost every drug states if a patient has had allergic reaction to the mikhizumab or any of its components of course they shouldn't be given the drug. There is probably a caution. I have to look at the packages that are about administration of live vaccines in patients on mikizumab so there will have to be an approach to dealing with that. But other than that there are not a lot of exclusions. There isn't any reason why this couldn't be used even first line for patients with psoriasis and I would say in particular if a patient needs to clear quickly for some urgent reason this would probably be the go to drug because it does work very quickly. The patients who are refractory to other biologics would have a good chance of clearing with this drug simply because it has better efficacy data, the data better especially passing 100 data than any of the other biologics. So I would say there's a lot I think that most patients would be good candidates for treatment with bimicizumab.

Who is eligible for treatment with bimekizumab? Are there any notable exclusion criteria?

Related CME